Pre-exposure to the cannabinoid receptor agonist CP 55,940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats

By Norwood C.S.   Cornish J.L.   Mallet P.E.   McGregor I.S.  

European Journal of Pharmacology, Vol. 465, Iss. 1, 2003-03 ,pp. : 105-114

Elsevier

Access to resources Recommend Favorite

Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaine

By Arnold J.C.   Topple A.N.   Hunt G.E.   McGregor I.S.  

European Journal of Pharmacology, Vol. 354, Iss. 1, 1998-07 ,pp. : 9-16

Elsevier

Access to resources Recommend Favorite

Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices

By Gifford A.N.   Samiian L.   Gatley S.J.   Ashby Jr. C.R.  

European Journal of Pharmacology, Vol. 324, Iss. 2, 1997-04 ,pp. : 187-192

Elsevier

Access to resources Recommend Favorite

Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat

By Costa B.   Parolaro D.   Colleoni M.  

European Journal of Pharmacology, Vol. 313, Iss. 1, 1996-10 ,pp. : 17-24

Elsevier

Access to resources Recommend Favorite

-Opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug-naive rats and mice

By Kuzmin A.V.   Semenova S.   Gerrits M.A.F.M.   Zvartau E.E.   Van Ree J.M.  

European Journal of Pharmacology, Vol. 321, Iss. 3, 1997-03 ,pp. : 265-271

Elsevier

Access to resources Recommend Favorite